591 related articles for article (PubMed ID: 23689659)
1. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
Cruz DN; Schmidt-Ott KM; Vescovo G; House AA; Kellum JA; Ronco C; McCullough PA
Contrib Nephrol; 2013; 182():117-36. PubMed ID: 23689659
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
Haase M; Müller C; Damman K; Murray PT; Kellum JA; Ronco C; McCullough PA
Contrib Nephrol; 2013; 182():99-116. PubMed ID: 23689658
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic therapies for chronic and acute decompensated heart failure: specific insights on cardiorenal syndromes.
Roubille F; Morena M; Leray-Moragues H; Canaud B; Cristol JP; Klouche K
Blood Purif; 2014; 37 Suppl 2():20-33. PubMed ID: 25196566
[TBL] [Abstract][Full Text] [Related]
4. Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
Tumlin JA; Costanzo MR; Chawla LS; Herzog CA; Kellum JA; McCullough PA; Ronco C
Contrib Nephrol; 2013; 182():158-73. PubMed ID: 23689661
[TBL] [Abstract][Full Text] [Related]
5. The role of the kidney in heart failure.
Metra M; Cotter G; Gheorghiade M; Dei Cas L; Voors AA
Eur Heart J; 2012 Sep; 33(17):2135-42. PubMed ID: 22888113
[TBL] [Abstract][Full Text] [Related]
6. Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
Mehta RL; Rabb H; Shaw AD; Singbartl K; Ronco C; McCullough PA; Kellum JA
Contrib Nephrol; 2013; 182():174-94. PubMed ID: 23689662
[TBL] [Abstract][Full Text] [Related]
7. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C
Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of renal dysfunction in heart failure.
Palazzuoli A; Beltrami M; Nodari S; McCullough PA; Ronco C
Rev Cardiovasc Med; 2011; 12(4):186-99. PubMed ID: 22249509
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome.
Ronco C; Cruz D; Noland BW
Semin Nephrol; 2012 Jan; 32(1):121-8. PubMed ID: 22365170
[TBL] [Abstract][Full Text] [Related]
10. Target organ cross talk in cardiorenal syndrome: animal models.
Bongartz LG; Braam B; Gaillard CA; Cramer MJ; Goldschmeding R; Verhaar MC; Doevendans PA; Joles JA
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1253-63. PubMed ID: 22914779
[TBL] [Abstract][Full Text] [Related]
11. [Cardio-renal axis: pathophysiological evidences and clinical implications].
Di Lullo L; Ronco C
G Ital Nefrol; 2017 Mar; 34(Suppl 69):4-10. PubMed ID: 28682024
[TBL] [Abstract][Full Text] [Related]
12. [Organ damage and cardiorenal syndrome in acute heart failure].
Casado Cerrada J; Pérez Calvo JI
Med Clin (Barc); 2014 Mar; 142 Suppl 1():26-31. PubMed ID: 24930080
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of cardiorenal syndrome in decompensated heart failure: role of lung-right heart-kidney interaction.
Guazzi M; Gatto P; Giusti G; Pizzamiglio F; Previtali I; Vignati C; Arena R
Int J Cardiol; 2013 Nov; 169(6):379-84. PubMed ID: 24182905
[TBL] [Abstract][Full Text] [Related]
14. [Biomarkers of cardiorenal syndrome].
Kuster N; Moréna M; Bargnoux AS; Leray H; Chenine L; Dupuy AM; Canaud B; Cristol JP
Ann Biol Clin (Paris); 2013; 71(4):409-18. PubMed ID: 23906568
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.
Zachariah D; Olechowski B; Kalra PR
J Ren Care; 2013 Sep; 39(3):128-39. PubMed ID: 23902278
[TBL] [Abstract][Full Text] [Related]
16. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil gelatinase-associated lipocalin and worsening renal function in acute heart failure: the plot thickens.
Damman K
J Cardiovasc Med (Hagerstown); 2013 Sep; 14(9):635-6. PubMed ID: 23903076
[No Abstract] [Full Text] [Related]
18. Heart functional and structural compendium of cardiosplenic and cardiorenal networks in acute and chronic heart failure pathology.
Halade GV; Kain V; Ingle KA
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H255-H267. PubMed ID: 29101178
[TBL] [Abstract][Full Text] [Related]
19. [Cardiorenal syndrome, current understanding].
Ronco F; Ronco C
Recenti Prog Med; 2009 Apr; 100(4):202-13. PubMed ID: 19554920
[TBL] [Abstract][Full Text] [Related]
20. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome.
Giam B; Kaye DM; Rajapakse NW
Heart Lung Circ; 2016 Aug; 25(8):874-80. PubMed ID: 27132623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
